OptiMOM-D

A randomised control trial to determine the optimal dose of domperidone for the treatment of lactation insufficiency in mothers of preterm infants born less than 30 weeks gestation, with the key objective to determine if administering a higher dose of domperidone (60mg/day) compared to a lower dose (30mg/day) results in a greater increase in daily breast milk supply after 3 weeks treatment